Bronchiectasis in pediatrics

Bronchiectasis in children is a long-term respiratory condition defined by a persistent productive cough, airway infection, and inflammation, with visible bronchial dilatation on chest computed tomography.It has a profound impact on children's well-being, daily life, and family economy.Prompt diagnosis is crucial, as early treatment can prevent progression and even reverse some changes.The condition's presentation and outcomes vary depending on the underlying causes, disease severity, and social or economic background.Thorough investigations to identify the underlying etiology are essential for optimizing treatment and preventing further lung damage.Pediatric bronchiectasis differs significantly from the adult form, with differences in diagnostic criteria, etiology, and treatment strategies.Although it is a substantial burden, bronchiectasis in children remains an underresearched area, highlighting the need for more focused efforts to improve care and reduce disparities.This narrative review explores the pathophysiology, diagnosis, and management of bronchiectasis in children.

Authors

Publication Details

Journal
Barcelona Respiratory Network
Published
2025-04-04
DOI
https://doi.org/10.23866/brnrev:2025-m0125
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bronchiectasis in pediatrics

Antonio Moreno, Eva Polverino, Laura Garriga-Grimau
Barcelona Respiratory Network
Cystic Fibrosis Research Advances
article

Bronchiectasis in pediatrics

Antonio Moreno, Eva Polverino, Laura Garriga-Grimau
article en

Abstract

Bronchiectasis in children is a long-term respiratory condition defined by a persistent productive cough, airway infection, and inflammation, with visible bronchial dilatation on chest computed tomography.It has a profound impact on children's well-being, daily life, and family economy.Prompt diagnosis is crucial, as early treatment can prevent progression and even reverse some changes.The condition's presentation and outcomes vary depending on the underlying causes, disease severity, and social or economic background.Thorough investigations to identify the underlying etiology are essential for optimizing treatment and preventing further lung damage.Pediatric bronchiectasis differs significantly from the adult form, with differences in diagnostic criteria, etiology, and treatment strategies.Although it is a substantial burden, bronchiectasis in children remains an underresearched area, highlighting the need for more focused efforts to improve care and reduce disparities.This narrative review explores the pathophysiology, diagnosis, and management of bronchiectasis in children.

Barcelona Respiratory NetworkVol. 11(1)
Pfizer, Sanofi, CSL Behring, Moderna, Insmed, Grifols
Openalex Percentile: Top 90%
Cystic Fibrosis Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.